Actionable Genes, Core Databases, and Locus-Specific Databases.

Hum Mutat 2016 12 26;37(12):1299-1307. Epub 2016 Sep 26.

Aix Marseille Univ, INSERM, GMGF, Marseille, France.

Adoption of next-generation sequencing (NGS) in a diagnostic context raises numerous questions with regard to identification and reports of secondary variants (SVs) in actionable genes. To better understand the whys and wherefores of these questioning, it is necessary to understand how they are selected during the filtering process and how their proportion can be estimated. It is likely that SVs are underestimated and that our capacity to label all true SVs can be improved. In this context, Locus-specific databases (LSDBs) can be key by providing a wealth of information and enabling classifying variants. We illustrate this issue by analyzing 318 SVs in 23 actionable genes involved in cancer susceptibility syndromes identified through sequencing of 572 participants selected for a range of atherosclerosis phenotypes. Among these 318 SVs, only 43.4% are reported in Human Gene Mutation Database (HGMD) Professional versus 71.4% in LSDB. In addition, 23.9% of HGMD Professional variants are reported as pathogenic versus 4.8% for LSDB. These data underline the benefits of LSDBs to annotate SVs and minimize overinterpretation of mutations thanks to their efficient curation process and collection of unpublished data.

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.23112DOI Listing
December 2016
90 Reads

Publication Analysis

Top Keywords

actionable genes
12
hgmd professional
8
svs actionable
8
locus-specific databases
8
318 svs
8
svs
6
572 participants
4
participants selected
4
sequencing 572
4
syndromes identified
4
susceptibility syndromes
4
selected range
4
identified sequencing
4
range atherosclerosis
4
true svs
4
svs 434%
4
phenotypes 318
4
svs improved
4
atherosclerosis phenotypes
4
cancer susceptibility
4

Similar Publications